SERUM HCG CONTROL SET (NEGATIVE, LOW POSITIVE AND HIGH POSITIVE)— 510(k) K974108

Name: FDA 510(k) clearance K974108
Creator: U.S. Food and Drug Administration
Published: 1997-11-26

Substantially Equivalent

Quidel Corp.

FDA 510(k) clearance K974108 for SERUM HCG CONTROL SET (NEGATIVE, LOW POSITIVE AND HIGH POSITIVE), Substantially Equivalent on 1997-11-26. Applicant: Quidel Corp.. Device class: 1.

Clearance details

Applicant: Quidel Corp.
Product code: Code JJX
Device class: Class 1
Regulation: 21 CFR 862.1660
Advisory panel: Clinical Chemistry
Date received: 1997-10-31
Decision date: 1997-11-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JJX

view all

K170678 — Beta-CrossLaps CalCheck 52017-04-04
K162173 — Elecsys CYFRA 21-1 CalCheck 52017-01-12
K162514 — Multichem A1c2016-10-26
K161874 — Audit MicroControls Linearity DROP LQ Blood Glucose2016-08-10
K161522 — LIAISON EBV IgM Serum Control Set2016-06-30

More clearances from Quidel Corp.

view all

K131813 — QUIDEL MOLECULAR RSV + HMPV ASSAY2013-09-06
K131728 — QUIDEL MOLECULAR INFLUENZA A + B ASSAY2013-08-29
K130398 — SOFIA(R) RSV FIA2013-08-13
K131166 — SOFIA(R) HCG FIA2013-08-02
K131606 — SOFIA INFLUENZA A+B FIA2013-07-05

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.